Main Sequence is a deep tech venture firm founded in 2017 that invests from seed to Series B in companies built on scientific research. Its About page describes the firm as co-founded by CSIRO, Australia's national science agency, and the firm's brand assets pair its logo with CSIRO's; the page does not describe CSIRO as an owner or shareholder of the manager, so the relationship is best read as a founding and continuing institutional association rather than ownership. The firm organises its investing around six challenge areas it names as: bridge the gap to space, decarbonise the planet, enable the next intelligence leap, feed 10 billion people, reach humanity scale healthcare, and supercharge industrial productivity. Its About page reports Fund 1 at $240 million, Fund 2 at $310 million, Fund 3 at $450 million commencing in 2023, and 51 companies across Funds 1 and 2.
Cylite (acquisition, 2024)